Paul Tudor Jones II (Tudor Investment) exit Regeneron Pharmaceuticals Inc
Paul Tudor Jones II (Tudor Investment) exit $-77.6M of disclosed value in Regeneron Pharmaceuticals Inc.
Signal
Investor Move
Action
Exit
Capital
$-77.6M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.